BioLase Technology Reports Record Sales.

SAN CLEMENTE, Calif.--(BW HealthWire)--Jan. 22, 1999--BioLase Technology, Inc. (Nasdaq:BLTI) today reported its highest sales ever in a single month.

Sales for December 1998 were a record $777,097. This represents a dramatic increase over sales for October and November. Total fourth quarter sales for the three months ended December 31, 1998 were $879,019.

"The record sales represent a turning point for BioLase. We believe this demonstrates market demand for our technologically and clinically superior products," remarked Jeffrey W. Jones, president and chief executive officer of BioLase. Jones further explained, "the sales were well distributed domestically and internationally, showing world wide recognition of BioLase's patented Hydrokinetic(tm) Technology. The December shipments further demonstrate that we have successfully transitioned from an R&D only company to production."

BioLase Technology, Inc. manufactures and markets advanced cosmetic, aesthetic, dental and surgical products, including laser systems, HydroKinetic(tm) surgical cutting systems and other laser and non-laser based products for the professional and home consumer markets. The company's products incorporate patented and patent-pending technologies that permit achieving results in unique ways.

The matters discussed in this news release include forward-looking statements which are subject to various risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated in such forward-looking statements. Such risks, uncertainties and other factors include, but are not limited to, the effect of actions of third parties, including governmental officials, the timely development and acceptance of new products, the impact of competitive products and pricing, and other risks detailed from time-to-time in the Company's filings with the Securities and Exchange Commission, including the reports on Forms 10-K and 10-Q. These forward-looking statements represent the Company's judgment as of the date of this release. The Company disclaims, however, any intent or obligation to update these forward-looking statements.